PCVX Company Profile and Key Details

Q: Who are the executives of PCVX?

Mr. Harp Dhaliwal M.B.A.Senior Vice President of Commercial Manufacturing & Supply ChainMs. Janet GraesserVice President of Corporation Communications & Investor RelationsMs. Elvia CowanSenior Vice President of Fin. & Principal Accounting OfficerKaren AldereteExecutive Director of HRMr. Grant E. Pickering M.B.A.Co-Founder, Chief Executive Officer & DirectorDr. Jeff Fairman Ph.D.Co-Founder & Vice President of ResearchDr. Ashish Khanna M.B.A., Ph.D.Co-FounderMr. Andrew L. Guggenhime M.B.A.Pres, Chief Financial Officer & Principal Accounting OfficerMr. James Wassil M.B.A., M.S.Executive Vice President & Chief Operating OfficerMr. Paul W. Sauer M.B.A., MBASenior Vice President of Process Devel. & ManufacturingMr. Mikhail Eydelman J.D.Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.

NASDAQ : PCVX

Vaxcyte

$52.11

0.67+1.30%

At Close 4:00 PM

60.86

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Vaxcyte, Inc. (PCVX) stock surged +1.30%, trading at $52.11 on NASDAQ, up from the previous close of $51.44. The stock opened at $52.16, fluctuating between $50.83 and $52.95 in the recent session.

Stock Snapshot

51.44

Prev. Close

7.52B

Market Cap

50.83

Day Low

-7.56

P/E Ratio

-6.89

EPS (TTM)

-3.82

Cash Flow per Share

52.16

Open

144.4M

Number of Shares

52.9499

Day High

90%

Free Float in %

13.01

Book Value

1.43M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 22, 2026	51.71	52.95	50.82	52.11	1.47M
Jun 18, 2026	52.00	53.48	50.24	51.44	2.84M
Jun 17, 2026	49.35	51.91	49.35	50.67	1.12M
Jun 16, 2026	49.57	50.30	48.89	49.31	999.03K
Jun 15, 2026	47.71	50.05	47.48	49.56	1.73M
Jun 12, 2026	47.30	48.44	46.71	47.46	1.03M
Jun 11, 2026	46.04	47.65	45.30	47.29	2.04M
Jun 10, 2026	46.80	47.77	45.31	45.42	1.03M
Jun 09, 2026	46.93	47.60	46.10	46.88	1.32M
Jun 08, 2026	47.76	48.25	45.57	46.33	1.34M
Jun 05, 2026	48.70	49.19	47.23	47.36	1.11M
Jun 04, 2026	47.66	49.15	47.43	48.76	1.23M
Jun 03, 2026	47.50	47.58	46.58	46.93	1.4M
Jun 01, 2026	51.01	51.01	48.66	48.91	1.37M
May 29, 2026	51.09	51.49	50.44	51.40	1.41M
May 28, 2026	51.02	51.25	49.91	51.06	1.33M
May 27, 2026	50.16	51.21	49.79	51.02	1.41M
May 26, 2026	47.74	50.25	47.10	50.11	1.32M
May 22, 2026	47.35	48.37	47.00	47.30	1.33M
May 21, 2026	46.87	47.58	46.51	47.39	1.18M

Contact Details

San Carlos, CA 94070

United States

https://vaxcyte.com 650 837 0111

About Company

Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.

Stock Peers

ARGX

26.03+2.97%

argenx SE$903.75 REGN

2.56+0.42%

Regeneron Pharmaceuticals, Inc.$612.50 UTHR

1.70998+0.32%

United Therapeutics Corporation$538.30 MDGL

7.13+1.41%

Madrigal Pharmaceuticals, Inc.$512.88 VRTX

15.16+3.36%

Vertex Pharmaceuticals Incorporated$466.79 KRYS

-4.63-1.33%

Krystal Biotech, Inc.$343.43 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

21.08+7.47%

Praxis Precision Medicines, Inc.$303.39 ALNY

8.32+2.99%

Alnylam Pharmaceuticals, Inc.$286.41 LGND

-12.71-4.62%

Ligand Pharmaceuticals Incorporated$262.17

Frequently Asked Questions

What is the current Vaxcyte, Inc. (PCVX) stock price?

Vaxcyte, Inc. (NASDAQ: PCVX) stock price is $52.11 in the last trading session. During the trading session, PCVX stock reached the peak price of $52.95 while $50.83 was the lowest point it dropped to. The percentage change in PCVX stock occurred in the recent session was 1.3% while the dollar amount for the price change in PCVX stock was $0.67.

PCVX's industry and sector of operation?

The NASDAQ listed PCVX is part of Biotechnology industry that operates in the broader Healthcare sector. Vaxcyte, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PCVX?

Mr. Harp Dhaliwal M.B.A.
Senior Vice President of Commercial Manufacturing & Supply Chain
Ms. Janet Graesser
Vice President of Corporation Communications & Investor Relations
Ms. Elvia Cowan
Senior Vice President of Fin. & Principal Accounting Officer
Karen Alderete
Executive Director of HR
Mr. Grant E. Pickering M.B.A.
Co-Founder, Chief Executive Officer & Director
Dr. Jeff Fairman Ph.D.
Co-Founder & Vice President of Research
Dr. Ashish Khanna M.B.A., Ph.D.
Co-Founder
Mr. Andrew L. Guggenhime M.B.A.
Pres, Chief Financial Officer & Principal Accounting Officer
Mr. James Wassil M.B.A., M.S.
Executive Vice President & Chief Operating Officer
Mr. Paul W. Sauer M.B.A., MBA
Senior Vice President of Process Devel. & Manufacturing
Mr. Mikhail Eydelman J.D.
Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.

How PCVX did perform over past 52-week?

PCVX's closing price is 79.19% higher than its 52-week low of $29.08 where as its distance from 52-week high of $65.00 is -19.83%.

How many employees does PCVX have?

Number of PCVX employees currently stands at 414.

Link for PCVX official website?

Official Website of PCVX is: https://vaxcyte.com

How do I contact PCVX?

PCVX could be contacted at phone 650 837 0111 and can also be accessed through its website. PCVX operates from 825 Industrial Road, San Carlos, CA 94070, United States.

How many shares of PCVX are traded daily?

PCVX stock volume for the day was 1.43M shares. The average number of PCVX shares traded daily for last 3 months was 1.43M.

What is the market cap of PCVX currently?

The market value of PCVX currently stands at $7.52B with its latest stock price at $52.11 and 144.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	414
Beta	1.24
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	414
Beta	1.24
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PCVX Company Profile and Key Details

Vaxcyte

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways